TokenPost·
Eli Lilly Raises 2026 Revenue Outlook to $91 Billion to $92 Billion
Third-quarter revenue rose 39% to $24.397 billion, led by Mounjaro and Zepbound sales.
More news
- The BlockUniswap Labs opens fee conversion tool TJAR to apps, starting with Robinhood
- TokenPostAirtm Plans Retailer Payments Through BVNK Integration on Stellar
- Crypto BriefingPentagon reshuffle: Defense Secretary Hegseth removes top general
- TokenPostFed Reserves One 2027 Meeting for Strategy, Leaving Seven for Rate Decisions
- CryptoSlateStrategy’s STRC nears $100 level that could reopen a Bitcoin funding channel
- TokenPostTravala Builds AVA Lockups Into New Crypto Payment Partner Program